Biomarin Pharmaceutical
Price & Volume
Stats
See more52W Range | $52.47-$73.51 |
Market Cap | $10.3B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $3B |
Revenue Growth (YoY) | 15.9% |
Gross Profit (12 Mos) | $2.5B |
Diluted EPS | $3.39 |
News
See moreYahoo Finance • 9 days ago
Growth and Pipeline Keep BioMarin Pharmaceutical Inc. (BMRN) Attractive for Investors
Yahoo Finance • 19 days ago
Sum Up The Pieces: MDYV Could Be Worth $94
Yahoo Finance • last month
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): A Value Investing Case Study in Undervaluation
Yahoo Finance • 2 months ago
Bernstein Maintains a Buy Rating on BioMarin Pharmaceutical (BMRN)
About
CEO | Mr. Alexander Hardy |
CFO | Mr. Brian R. Mueller CPA |
Address | 770 Lindaro Street, San Rafael, CA, United States, 94901 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3,040 |
